658 related articles for article (PubMed ID: 17453713)
1. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
2. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
3. Infiltration of inflammatory cells through brain endothelium.
Couraud PO
Pathol Biol (Paris); 1998 Mar; 46(3):176-80. PubMed ID: 9769913
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
McCandless EE; Klein RS
Expert Rev Mol Med; 2007 Jul; 9(20):1-19. PubMed ID: 17637110
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of the blood-brain barrier.
Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
[TBL] [Abstract][Full Text] [Related]
6. Development of the blood-brain barrier.
Engelhardt B
Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
[TBL] [Abstract][Full Text] [Related]
7. The critical component to establish in vitro BBB model: Pericyte.
Lai CH; Kuo KH
Brain Res Brain Res Rev; 2005 Dec; 50(2):258-65. PubMed ID: 16199092
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
Hamann I; Zipp F; Infante-Duarte C
J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
[TBL] [Abstract][Full Text] [Related]
9. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
10. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.
Cardoso FL; Brites D; Brito MA
Brain Res Rev; 2010 Sep; 64(2):328-63. PubMed ID: 20685221
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
12. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
13. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Minagar A; Maghzi AH; McGee JC; Alexander JS
Neurol Res; 2012 Oct; 34(8):738-45. PubMed ID: 22828184
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier and treatment of central nervous system tumors.
Wiranowska M
J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
[TBL] [Abstract][Full Text] [Related]
16. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.
Prat A; Biernacki K; Antel JP
J Autoimmun; 2005 Mar; 24(2):119-24. PubMed ID: 15829404
[TBL] [Abstract][Full Text] [Related]
18. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
Grammas P; Martinez J; Miller B
Expert Rev Mol Med; 2011 Jun; 13():e19. PubMed ID: 21676288
[TBL] [Abstract][Full Text] [Related]
19. Current concepts of blood-brain barrier development.
Liebner S; Czupalla CJ; Wolburg H
Int J Dev Biol; 2011; 55(4-5):467-76. PubMed ID: 21769778
[TBL] [Abstract][Full Text] [Related]
20. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Alvarez JI; Dodelet-Devillers A; Kebir H; Ifergan I; Fabre PJ; Terouz S; Sabbagh M; Wosik K; Bourbonnière L; Bernard M; van Horssen J; de Vries HE; Charron F; Prat A
Science; 2011 Dec; 334(6063):1727-31. PubMed ID: 22144466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
